A suite of standees, posters, a brochure, and a presentation deck — designed for Eyestem's international debut at Asia's leading cell therapy and biotech conference in Singapore.
The context behind a high-stakes international conference debut.
Eyestem is a Bangalore-based cell therapy company developing Eyecyte-RPE — a scalable cell replacement therapy for Dry AMD, the largest cause of incurable blindness in people above 60. Backed by a world-class team of clinical trial, cell therapy, and ophthalmology experts, Eyestem's long-term mission is to democratise access to next-generation cell therapies for the majority of the global population.
To showcase at an international healthcare conference in Singapore, Eyestem needed a suite of print collaterals capable of representing the brand to a global audience of healthcare professionals, researchers, investors, and clinical leaders — many encountering Eyestem for the first time in a competitive conference environment. The materials had to simultaneously project scientific credibility with the rigour a specialist audience demands, and create a visual impression memorable enough to follow a delegate home in their briefcase.
How First Launch approached a brief demanding scientific rigour and visual distinction in equal measure.
Every piece designed to work in the moment of first encounter — and again when taken home.
The complete Eyestem conference collateral suite on Behance.
Collateral that looks genuinely considered signals a company that takes presentation as seriously as the science itself.
Common questions about the Eyestem conference collateral project and First Launch's approach to healthcare print design.
Take a look at First Launch case studies for tips & tricks on how to improve your own brand performance
A Bangalore interior design and construction studio went from zero search visibility to Page 1 rankings and 5.2x more impressions...
One content system change took Line of Thought from 105 to 235 followers — with 39% of the audience in...
A greenfield Google Ads build for a US health-tech education platform. First 30 days. 148.5 course sign-ups. 24.79% conversion rate....